admin
Senators Ron Johnson and Rand Paul this week released documents taken from Dr. Anthony Fauci’s government records that include a May 27, 2021 email from longtime FDA official Janet Woodcock urging NIH leaders to study hard‑to‑classify reports of adverse events after COVID‑19 vaccination. Dr. Fauci forwarded her warning to then‑NIH leadership and suggested looping in CDC Director Rochelle Walensky — but it is still unclear whether any full, independent NIH‑funded study was launched.
What the Woodcock email actually says
Woodcock’s note is plain and pointed: clinicians were reporting symptoms that “do not fit together into a distinctive syndrome” and many were “not easily quantifiable” with routine lab tests. She told NIH leaders the reports deserved study even if vaccine makers would not help, and warned that if you “let a problem fester, then it will come back to bite you later.” Fauci’s forwarded message to Dr. Francis Collins acknowledged the concern and suggested bringing in CDC. That is the new, central fact the senators released — not speculation, but an internal plea from a senior FDA official.
Why this matters for vaccine safety and public trust
Woodcock’s point about surveillance systems is important. Passive systems like VAERS are meant to flag signals, not prove cause. But her email warns that some complaints were the sort that VAERS and routine electronic‑record checks might miss. In plain terms: doctors were seeing strange, lingering problems and a top FDA leader thought they deserved serious study funded by NIH. If the federal health apparatus shrugged and didn’t follow up, that is a failure of both science and public trust.
Republicans press for answers — and they should
Senators Johnson and Paul framed the release as evidence of officials knowing about signals and not doing enough. They have been pursuing Fauci’s files and have used committee powers to force document disclosures and testimony. Whether you like their politics or not, the basic question is straightforward: did the nation’s research machinery — with billions of NIH dollars available — start the kind of study Woodcock urged? If not, why not? That’s a question taxpayers and patients have a right to have answered.
Where we go from here: study, explain, and be honest
Federal agencies should stop hiding behind jargon and caveats. If Woodcock was right to worry, launch transparent, prospective studies now and give clinicians clear guidance. If the signals were examined and found not to show causation, publish the methods and the results so people can see how the conclusion was reached. The default of secrecy and silence only fuels doubt — and as Woodcock warned, problems that fester come back to bite you. Congress should push for clear answers, and the public should demand nothing less.
